Latest StemPoint Capital LP Stock Portfolio
$680Million– No. of Holdings #42
StemPoint Capital LP Performance:
2024 Q2: -4.62%YTD: 8.23%
Performance for 2024 Q2 is -4.62%, and YTD is 8.23%.
About StemPoint Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $680.6 Millions as of 30 Jun, 2024.
The top stock holdings of STEMPOINT CAPITAL LP are SNDX, ROIV, IMVT. The fund has invested 8.5% of it's portfolio in SYNDAX PHARMACEUTICALS INC and 8.4% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off ELI LILLY & CO (LLY), TARSUS PHARMACEUTICALS INC (TARS) and TOURMALINE BIO INC stocks. They significantly reduced their stock positions in INSMED INC (INSM) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). STEMPOINT CAPITAL LP opened new stock positions in IMMUNOCORE HLDGS PLC (IMCR), MERCK & CO INC (MRK) and GSK PLC. The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), BIOHAVEN LTD and SPYRE THERAPEUTICS INC (AGLE).
The top stock holdings of STEMPOINT CAPITAL LP are SNDX, ROIV, IMVT. The fund has invested 8.5% of it's portfolio in SYNDAX PHARMACEUTICALS INC and 8.4% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off ELI LILLY & CO (LLY), TARSUS PHARMACEUTICALS INC (TARS) and TOURMALINE BIO INC stocks. They significantly reduced their stock positions in INSMED INC (INSM) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). STEMPOINT CAPITAL LP opened new stock positions in IMMUNOCORE HLDGS PLC (IMCR), MERCK & CO INC (MRK) and GSK PLC. The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), BIOHAVEN LTD and SPYRE THERAPEUTICS INC (AGLE).
StemPoint Capital LP Equity Portfolio Value
Last Reported on: 13 Aug, 2024
StemPoint Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that STEMPOINT CAPITAL LP made a return of -4.62% in the last quarter. In trailing 12 months, it's portfolio return was NA%.
New Buys
| Ticker | $ Bought |
|---|---|
| immunocore hldgs plc | 23,001,200 |
| merck & co inc | 20,306,900 |
| gsk plc | 18,936,800 |
| denali therapeutics inc | 11,656,900 |
| celldex therapeutics inc new | 10,693,400 |
| tscan therapeutics inc | 9,887,310 |
| edgewise therapeutics inc | 9,763,470 |
| corbus pharmaceuticals hldgs | 9,183,850 |
New stocks bought by StemPoint Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| protara therapeutics inc | 1,068 |
| biohaven ltd | 458 |
| spyre therapeutics inc | 383 |
| arcellx inc | 300 |
| fulcrum therapeutics inc | 242 |
| immunovant inc | 222 |
| syndax pharmaceuticals inc | 156 |
| merus n v | 146 |
Additions to existing portfolio by StemPoint Capital LP
Reductions
| Ticker | % Reduced |
|---|---|
| insmed inc | -36.15 |
| arcutis biotherapeutics inc | -12.47 |
StemPoint Capital LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| achilles therapeutics plc | -1,732,190 |
| taysha gene therapies inc | -3,121,940 |
| acelyrin inc | -4,824,720 |
| annexon inc | -4,338,690 |
| tourmaline bio inc | -6,279,620 |
| anaptysbio inc | -6,070,220 |
| astria therapeutics inc | -2,676,880 |
| avadel pharmaceuticals plc | -3,777,620 |
StemPoint Capital LP got rid off the above stocks
Sector Distribution
STEMPOINT CAPITAL LP has about 87.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.8 |
| Others | 12.2 |
Market Cap. Distribution
STEMPOINT CAPITAL LP has about 4.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 43 |
| SMALL-CAP | 29.9 |
| UNALLOCATED | 18.3 |
| MEGA-CAP | 3 |
| MICRO-CAP | 3 |
| LARGE-CAP | 1.7 |
| NANO-CAP | 1.1 |
Stocks belong to which Index?
About 55.6% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 52.6 |
| Others | 44.4 |
| S&P 500 | 3 |
StemPoint Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of StemPoint Capital LP
STEMPOINT CAPITAL LP has 42 stocks in it's portfolio. About 55.4% of the portfolio is in top 10 stocks. CABA proved to be the most loss making stock for the portfolio. MRUS was the most profitable stock for STEMPOINT CAPITAL LP last quarter.
Last Reported on: 13 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHL | achilles therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 4.55 | 561,418 | 30,984,700 | added | 300 | ||
| AGLE | spyre therapeutics inc | 1.04 | 300,900 | 7,074,160 | added | 383 | ||
| ANAB | anaptysbio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANNX | annexon inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLT | applied therapeutics inc | 3.04 | 4,422,640 | 20,653,700 | added | 119 | ||
| ARQT | arcutis biotherapeutics inc | 2.64 | 1,930,780 | 17,956,300 | reduced | -12.47 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 2.72 | 5,325,460 | 18,532,600 | added | 79.57 | ||
| BDTX | black diamond therapeutics i | 0.92 | 1,348,400 | 6,283,530 | new | |||
| CABA | cabaletta bio inc | 2.59 | 2,356,210 | 17,624,400 | added | 134 | ||
| CLDX | celldex therapeutics inc new | 1.57 | 288,934 | 10,693,400 | new | |||
| CRBP | corbus pharmaceuticals hldgs | 1.35 | 202,958 | 9,183,850 | new | |||
| CRNX | crinetics pharmaceuticals in | 7.25 | 1,102,190 | 49,367,100 | added | 77.83 | ||
| DNLI | denali therapeutics inc | 1.71 | 502,020 | 11,656,900 | new | |||
| EFTR | effector therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EWTX | edgewise therapeutics inc | 1.44 | 542,114 | 9,763,470 | new | |||
| FOLD | amicus therapeutics inc | 4.36 | 2,990,090 | 29,661,700 | added | 93.27 | ||
| FULC | fulcrum therapeutics inc | 1.27 | 1,392,930 | 8,636,150 | added | 242 | ||
| IDYA | ideaya biosciences inc | 1.05 | 203,574 | 7,147,480 | added | 132 | ||